Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© 2019 John Wiley & Sons, Ltd. The inherited bleeding disorders (IBDs) are a heterogeneous group of disorders affecting the hemostatic system. This chapter covers the mechanisms of normal hemostasis and an approach to the clinical and laboratory hematological assessment of a patient with a suspected IBD. The three main steps of primary hemostasis are platelet adhesion, platelet activation, and platelet aggregation and platelet plug formation. Secondary hemostasis usually occurs simultaneously with primary hemostasis. Fibrinolysis is tightly regulated by the fibrinolytic system. Fibrinolysis is initiated by the proteases tissue plasminogen activator (tPA) or urokinase-like plasminogen activator. Inherited bleeding disorders may manifest with a variety of bleeding symptoms. There may be considerable variability in symptom severity even in patients affected by the same disorder. An accurate diagnosis is important as the impact is far-reaching, especially with precautions that affect perioperative management, work, and lifestyle activities as well as implications for screening and investigation of family members.

Original publication





Book title

Inherited Bleeding Disorders in Women

Publication Date



1 - 12